Clinicopathological study of pseudomyogenic hemangioendothelioma
Abstract Objectives Pseudomyogenic hemangioendothelioma (PHE) is a rare intermediate hemangioendothelioma. This article aims to study the clinicopathological features of PHE. Methods We collected the clinicopathological features of 10 new PHE, and examined their molecular pathological features by fl...
Main Authors: | Ningning Yang, Yuchen Huang, Panpan Yang, Wentian Yan, Shan Zhang, Nan Li, Zhenzhong Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13000-023-01309-9 |
Similar Items
-
Primary pseudomyogenic hemangioendothelioma of the vulva: a rare location for a rare entity
by: Yue-Fang Sun, et al.
Published: (2019-06-01) -
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
by: Shinya Otani, et al.
Published: (2019-09-01) -
Pseudomyogenic hemangioendothelioma of bone with rare WWTR1‐FOSB fusion gene: Case report and literature review
by: Khaled A. Murshed, et al.
Published: (2021-03-01) -
A rare case of pseudomyogenic hemangioendothelioma (PHE)/epithelioid sarcoma-like hemangioendothelioma (ES-H) of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature
by: Yan Ge, et al.
Published: (2019-07-01) -
Molecularly Confirmed Pseudomyogenic Hemangioendothelioma with Unusual EGFL7::FOSB Fusion in the Head and Neck Region of an Older Patient
by: Dong Ren, et al.
Published: (2024-02-01)